USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
A Collaborative Business Model With Focus on Stem Cells, Chimeric Antigen Receptor T (CAR-T) Cells and Combination Therapies Will Propel Market Growth
11-Mar-2019
North America
Market Research
PA16-01-00-00-00
HC03141-NA-MR_22920
The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule therapies, with cell therapies dominating the space. The study on the "Global Cell Therapy Market, 2018, Companies to Action” presents an overview of the global cell therapy landscape, with an emphasis on the key game-changing companies disrupting this market. The study highlights the emerging companies across regions that support the development and manufacturing of novel cell therapies.
With the changing market landscape, big pharma and biopharma participants, are looking toward the adoption of a collaborative business approach by either entering into co-development and/or co-commercialization agreements or acquiring smaller, niche participants so as to achieve a competitive advantage with respect to a specific therapy area or technology. The study also delves into some of the leading strategies adopted by market participants in order to succeed in this highly dynamic market. In addition to the above-mentioned strategic analysis, information such as risk sharing and fast to market business models of some of the emerging business models across the cell therapy market is also provided.
Research Highlights
This study identifies some of the strategies adopted by these game-changing companies with respect to key market-growth opportunities such as the use of combination therapies, manufacturing advancement and automation, adoption of newer gene-editing technologies such as CRISPR/Cas9, and so on. The study also highlights some collaborations and partnerships between these disruptive participants and throws some light on their upcoming drug pipeline; thereby, highlighting their contribution to this market. Additionally, it gives an insight into the leading strategic imperatives shaping the global industry and its long-term implication on market growth.
Key Issues Addressed
- What are the key market opportunities in the global cell therapy market?
- What is the impact of external industry environment on market growth?
- Which are some of the unique participants that are introducing cutting-edge therapies in this segment?
- What are the strategic imperatives to be adopted by these participants to bring about this market transformation?
- What is the growth potential of this rapidly expanding cell therapy market?
- What are some key factors for success in the global cell therapy market?
Key Findings—Analysis of Companies to Action
Key Findings—Analysis of Companies to Action (continued)
Scope and Segmentation
Key Questions Addressed in this Study
Companies to Action Value Creators
Opportunities and Threats
Market Definitions
Market Segmentation
Cell Therapy Value Chain
Vendor Ecosystem
Impact of Key Market Influencers
Top 3 Trends and Vendor Strategies
Key Market Participants Aligned with Top 3 Trends
Cell Therapy—Vendor Landscape
Juno Therapeutics—Overview
Juno Therapeutics—Technology Platforms
Juno Therapeutics—Major Partnerships and Agreements
bluebird bio—Business Overview
bluebird bio—Technology Platform
bluebird bio—Major Partnerships and Agreements
Kite Pharma—Overview
Kite Pharma—Key Technology/ Product/Services
Kite Pharma—Case Example and Recent Developments
Adaptimmune—Overview
Adaptimmune—Technology Platforms
Adaptimmune—Case Example and Recent Developments
Oxford BioMedica—Overview
Oxford BioMedica—Technology Platform
Oxford BioMedica—Case Example and Recent Developments
JCR Pharmaceuticals—Overview
JCR Pharmaceuticals—Technology Platforms
JCR Pharmaceuticals—Case Example and Recent Developments
Sangamo Therapeutics—Company Overview
Sangamo Therapeutics—Value Proposition
DiscGenics—Company Overview
DiscGenics—Value Proposition
TiGenix—Company Overview
TiGenix—Value Proposition
Bone Therapeutics—Company Overview
Bone Therapeutics—Value Proposition
Cell Medica—Company Overview
Cell Medica—Value Proposition
Mesoblast—Company Overview
Mesoblast—Value Proposition
Cynata Therapeutics—Company Overview
Cynata Therapeutics—Value Proposition
Medipost—Company Overview
Medipost—Value Proposition
Anterogen—Company Overview
Anterogen—Value Proposition
Pharmicell—Company Overview
Pharmicell—Value Proposition
Short Profiles of Digital Pathology Companies
Short Profiles of Digital Pathology Companies (continued)
Short Profiles of Digital Pathology Companies (continued)
Short Profiles of Digital Pathology Companies (continued)
Transformation in the Industry Ecosystem
Five Major Growth Opportunities
Strategic Imperatives for Growth
Conclusion—Key Takeaways
Legal Disclaimer
Abbreviation List
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Highlights
This study identifies some of the strategies adopted by these game-changing companies with respect to key market-growth opportunities such as the use of combination therapies, manufacturing advancement and automation, adoption of newer gene-editing technologies such as CRISPR/Cas9, and so on. The study also highlights some collaborations and partnerships between these disruptive participants and throws some light on their upcoming drug pipeline; thereby, highlighting their contribution to this market. Additionally, it gives an insight into the leading strategic imperatives shaping the global industry and its long-term implication on market growth.
Key Issues Addressed
- What are the key market opportunities in the global cell therapy market?
- What is the impact of external industry environment on market growth?
- Which are some of the unique participants that are introducing cutting-edge therapies in this segment?
- What are the strategic imperatives to be adopted by these participants to bring about this market transformation?
- What is the growth potential of this rapidly expanding cell therapy market?
- What are some key factors for success in the global cell therapy market?
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Aarti Chitale |
| Industries | Healthcare |
| WIP Number | PA16-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9571-B1,99C1-B1,9568-B1,9611-B1 |
Global Cell Therapy Market—Companies to Action, 2018
$3,000.00
Special Price $2,250.00 save 25 %